Trial intelligence / Profile preview

Hypertonic saline in mechanically ventilated patients with acute respiratory distress syndrome

ACTRN12615001282572Phase 2Completed

Sponsor
Shailesh Bihari
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of hypertonic saline in acute respiratory distress syndrome (ARDS), sponsored by Shailesh Bihari. Primary endpoint: Composite clinical improvement endpoint. Started Oct 2016; status: completed.

02

Drugs

hypertonic saline
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on ACTRN12615001282572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615001282572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call